| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2bcaf91101a370a3d64e3190366357f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1027 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10 |
| filingDate |
2020-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d271a199f586b71bc5ef40ea73cbfd5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfdeabf0ffe07381b96219fa9784012d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91f0a2cea3db4a395f1619cc0c976430
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4c2db1ee8212952ecc6af61009faa5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_845734d885abdef80b1b29b6bab46f02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d7367f4bd38ac85911f9f313b1f0d85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4eaabe0772cd4270cf77bea5612da574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b590f21c4fcc941dd968c02f9ebbc139 |
| publicationDate |
2022-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2022195016-A1 |
| titleOfInvention |
Biological and synthetic molecules inhibiting respiratory syncytial virus infection |
| abstract |
The present invention relates to a peptide with a length of 25 amino acids or less comprising the sequence X 1 -X 2 -X 3 -X 4 -X 5 -X 6 -X 7 -X 8 -X 9 -X 10 -X 11 -X 12 -X 13 (SEQ ID No: 1) as well as to A peptide with a length of 25 amino acids or less comprising the sequence X 1 -X 2 -X 3 -X 4 -X 5 -X 6 -X 7 -X 8 -X 9 -X 10 -X 11 -X 12 -X 13 -X 14 (SEQ ID No: 2). The present invention further relates to a nanostructure comprising a nucleic acid scaffold and at least two peptide moieties, wherein the sequence of each of the at least two peptide moieties is independently selected from the sequence of the peptide of the invention as well as pharmaceutical compositions, nucleic acids, methods and uses related thereto. |
| priorityDate |
2019-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |